Method of treating inflammation in mammals utilizing ketobutyrolactones and furylbutyrolactones
US4883813A · kind A · utility
4Cited by
0References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 24, 1988 |
| Grant date | Nov 28, 1989 |
| Priority date | — |
| Expiry date | Aug 24, 2008 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P29/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Treatment of inflammation in mammals utilizing selected ketobutyrolactones and furylbutyrolactones. Treatment is applicable to both acute or chronic inflammation. Antiviral activity of methylfurylbutyrolactone is also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.